Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
23.41
-0.15 (-0.64%)
At close: Sep 16, 2025, 4:00 PM EDT
23.70
+0.29 (1.24%)
After-hours: Sep 16, 2025, 4:49 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.41 billion as of September 16, 2025. Its market cap has decreased by -39.00% in one year.
Market Cap
1.41B
Enterprise Value
432.98M
1-Year Change
-39.00%
Ranking
Category
Stock Price
$23.41
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.41B, an increase of 129.22%. That is a compound annual growth rate of 21.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.42B | -54.13% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |